EC workshop on pharmaceutical/device borderline issues:
This article was originally published in Clinica
Executive Summary
The European Commission is to hold a workshop on October 28 on the overlap between the pharmaceutical directives and other directives covering products that are on its borderline, including medical devices. This is a key issue for manufacturers of drug/device combination products, and products on the drug/device borderline who are still unclear to what extent the new pharmaceutical directive will have supremacy over medical device regulations.